Predictors of Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Receiving EGFR Tyrosine Kinase Inhibitors: A Systematic Review and Meta-Analysis.
Buonerba C, Iaccarino S, Dolce P, Pagliuca M, Izzo M, Scafuri L, Costabile F, Riccio V, Ribera D, Mucci B, Carrano S, Picozzi F, Bosso D, Formisano L, Bianco R, De Placido S, Di Lorenzo G.
Buonerba C, et al. Among authors: dolce p.
Cancers (Basel). 2019 Aug 28;11(9):1259. doi: 10.3390/cancers11091259.
Cancers (Basel). 2019.
PMID: 31466227
Free PMC article.
Review.